Quinolone-Induced Upregulation of Osteopontin Gene Promoter Activity in Human Lung Epithelial Cell Line A549

被引:4
|
作者
Shiratori, Beata [1 ]
Zhang, Jing [2 ]
Usami, Osamu [1 ]
Chagan-Yasutan, Haorile [1 ]
Suzuki, Yasuhiko [3 ]
Nakajima, Chie [3 ]
Uede, Toshimitsu [4 ]
Hattori, Toshio [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Div Emerging & Infect Dis, Sendai, Miyagi 980, Japan
[2] FUSO Pharmaceut Ind Ltd, Ctr Res & Dev, Osaka, Japan
[3] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan
[4] Hokkaido Univ, Inst Genet Med, Div Mol Immunol, Sapporo, Hokkaido, Japan
基金
日本科学技术振兴机构;
关键词
POSTTRANSLATIONAL MODIFICATIONS; HOST-RESISTANCE; CYTOKINE; EXPRESSION; MOXIFLOXACIN; ACTIVATION; FLUOROQUINOLONE; PHOSPHORYLATION; IDENTIFICATION; CIPROFLOXACIN;
D O I
10.1128/AAC.06062-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Quinolones, in addition to their antibacterial activities, act as immunomodulators. Osteopontin (OPN), a member of the extracellular matrix proteins, was found to play a role in the immune and inflammatory response. We found that quinolones significantly enhanced OPN secretion, namely, garenoxacin (220%), moxifloxacin (62%), gatifloxacin (82%), sparfloxacin, (79%), and sitafloxacin (60%). Enhancement of OPN secretion was shown to be due to the effect of quinolones on the OPN gene promoter activity. We also examined the role of quinolones on apoptosis and found that sparfloxacin decreased the late apoptosis of A549 cells, but garenoxacin did not show the antiapoptotic effect. The antiapoptotic effects of quinolones do not appear to be associated with OPN elevation.
引用
收藏
页码:2868 / 2872
页数:5
相关论文
共 50 条
  • [1] Cytotoxicity of gold(III) Complexes on A549 Human Lung Carcinoma Epithelial Cell Line
    Arsenijevic, Milos
    Milovanovic, Marija
    Volarevic, Vladislav
    Djekovic, Ana
    Kanjevac, Tatjana
    Arsenijevic, Nebojsa
    Dukic, Svetlana
    Bugarcic, Zivadin D.
    MEDICINAL CHEMISTRY, 2012, 8 (01) : 2 - 8
  • [2] Antineoplastic activity of metformin on the A549 human lung carcinoma cell line in vitro
    Dong, Xi-Lin
    Yang, Yuan-Li
    Sun, Bao-Ni
    Liu, Yan-Qin
    Zhou, Jing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10711 - 10717
  • [3] Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549
    Muroya, Mitsuaki
    Chang, Kyungho
    Uchida, Kanji
    Bougaki, Masahiko
    Yamada, Yoshitsugu
    BIOSCIENCE TRENDS, 2012, 6 (02) : 70 - 80
  • [4] Genotoxic effects of formaldehyde in the human lung cell line A549 and in primary human nasal epithelial cells
    Speit, Guenter
    Schmid, Oliver
    Neuss, Simone
    Schuetz, Petra
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (04) : 300 - 307
  • [5] Hypoxia induces hexokinase II gene expression in human lung cell line A549
    Riddle, SR
    Ahmad, A
    Ahmad, S
    Deeb, SS
    Malkki, M
    Schneider, BK
    Allen, CB
    White, CW
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (02) : L407 - L416
  • [6] Effects of Lung Carcinogens on PPARgamma Activity in A549 Cell Line
    Carrasco, Nestor
    Tennis, Meredith
    Nield, Lori
    FASEB JOURNAL, 2015, 29
  • [7] Antitumor Activity of Acriflavine in Lung Adenocarcinoma Cell Line A549
    Lee, Chia-Jen
    Yue, Chia-Herng
    Lin, Yu-Jie
    Lin, Yu-Yu
    Kao, Shao-Hsuan
    Liu, Jer-Yuh
    Chen, Yieng-How
    ANTICANCER RESEARCH, 2014, 34 (11) : 6467 - 6472
  • [8] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Ye, Bin
    Xie, Yan
    Qin, Zheng-hong
    Wu, Jun-chao
    Han, Rong
    He, Jing-kang
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1397 - 1401
  • [9] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Bin Ye
    Yan Xie
    Zheng-hong Qin
    Jun-chao Wu
    Rong Han
    Jing-kang He
    Acta Pharmacologica Sinica, 2011, 32 : 1397 - 1401
  • [10] Antitumor activity of interleukin-18 on A549 human lung cancer cell line
    Xiong, Donglan
    Feng, Rui
    Yang, Sheng
    Lin, Tingyan
    Chen, Xiangqi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1635 - 1641